Delivery Order SPE2DR25D1053-SPE2DR26FT299
Award Date 10/24/25
Potential Completion Date 11/17/25
Potential Value $35K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $22,762.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for GAMMAGARD S-D 10G on September 22, 2025, with completion required by October 14, 2025. This non-set-aside award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $22,762.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMMAGARD S-D 10 G, a specialized immunoglobulin therapeutic product. Issued on May 13, 2025, with a completion date of June 4, 2025, this non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The performance location is AmerisourceBergen's corporate office in...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $9,810.12 firm fixed price delivery order contract by the Defense Logistics Agency Troop Support Medical to provide 4562236003 GAMMAGARD LIQUID 10% VIAL 100ML. The place of performance will be in Conshohocken, Pennsylvania over a period of one month, from September 19, 2023 through October 11, 2023. No subcontractors or set aside designations were indicated. This delivery order was issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,327.20 to AmerisourceBergen Drug Corp for GAMUNEX-C 40 gram/400 mL vials on September 17, 2025, with an ultimate completion date of October 8, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and serves as a critical vendor for federal medical procurement needs,...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of Gammagard S-D 10 G (IGA), a pharmaceutical product, to the Defense Logistics Agency (DLA). The firm-fixed-price contract has a ceiling value of $8,970.40 and an ultimate completion date of May 8, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a delivery order contract worth $49,752.80 for the supply of GAMUNEX-C 40 gram/400 ml vials. The contract has a firm fixed price and an ultimate completion date of January 6, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
- The Defense Logistics Agency awarded a $40,532.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 milliliter vials, with an ultimate completion date of August 22, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order valued at $7,325.64 to AmerisourceBergen Drug Corp for GAMUNEX-C, a 10 gram/100 mL immunoglobulin vial product, with an ultimate completion date of August 21, 2025. This competitive award, issued on July 31, 2025, utilizes a firm fixed price contract type with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of GAMUNEX-C 20 gram/200 milliliter vials valued at $11,651.54 under a firm fixed-price contract with an ultimate completion date of August 18, 2025. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,831.41 to AmerisourceBergen Drug Corp for GAMUNEX-C 10 Gram/100 mL vial (100 mL), with an ultimate completion date of October 10, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded on September 19, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare...